NOT FOR DISTRIBUTION
Header cover image

Market Cap

CA$53.3m

Last Updated

2021/05/06 23:40 UTC

Data Sources

Company Financials +

Executive Summary

Nova Leap Health Corp. provides home and home health care services. More Details


Snowflake Analysis

Fair value with mediocre balance sheet.

Share Price & News

How has Nova Leap Health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NLH is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: NLH's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

1.3%

NLH

-0.3%

CA Healthcare

1.9%

CA Market


1 Year Return

97.4%

NLH

41.2%

CA Healthcare

36.9%

CA Market

Return vs Industry: NLH exceeded the Canadian Healthcare industry which returned 44.1% over the past year.

Return vs Market: NLH exceeded the Canadian Market which returned 37.1% over the past year.


Shareholder returns

NLHIndustryMarket
7 Day1.3%-0.3%1.9%
30 Day11.8%-1.8%2.2%
90 Day-3.8%0.8%8.3%
1 Year97.4%97.4%45.9%41.2%41.4%36.9%
3 Year123.5%123.5%42.6%24.5%30.1%17.7%
5 Yearn/a9.9%-13.9%60.1%36.2%

Long-Term Price Volatility Vs. Market

How volatile is Nova Leap Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Nova Leap Health undervalued compared to its fair value and its price relative to the market?

41.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NLH (CA$0.76) is trading below our estimate of fair value (CA$1.31)

Significantly Below Fair Value: NLH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NLH is poor value based on its PE Ratio (32.3x) compared to the CA Healthcare industry average (25.4x).

PE vs Market: NLH is poor value based on its PE Ratio (32.3x) compared to the Canadian market (16.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NLH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NLH is good value based on its PB Ratio (4.2x) compared to the CA Healthcare industry average (4.6x).


Future Growth

How is Nova Leap Health forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

23.3%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if NLH's forecast earnings growth is above the savings rate (1.5%).

Earnings vs Market: Insufficient data to determine if NLH's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NLH's revenue (23.3% per year) is forecast to grow faster than the Canadian market (7.3% per year).

High Growth Revenue: NLH's revenue (23.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NLH's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Nova Leap Health performed over the past 5 years?

20.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NLH has a large one-off gain of $1.2M impacting its December 31 2020 financial results.

Growing Profit Margin: NLH became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: NLH has become profitable over the past 5 years, growing earnings by 20.9% per year.

Accelerating Growth: NLH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: NLH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (97.3%).


Return on Equity

High ROE: NLH's Return on Equity (12.8%) is considered low.


Financial Health

How is Nova Leap Health's financial position?


Financial Position Analysis

Short Term Liabilities: NLH's short term assets ($4.3M) exceed its short term liabilities ($4.2M).

Long Term Liabilities: NLH's short term assets ($4.3M) exceed its long term liabilities ($3.5M).


Debt to Equity History and Analysis

Debt Level: NLH's debt to equity ratio (56.6%) is considered high.

Reducing Debt: Insufficient data to determine if NLH's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: NLH's debt is well covered by operating cash flow (54%).

Interest Coverage: Insufficient data to determine if NLH's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Nova Leap Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NLH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NLH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NLH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NLH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NLH's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.7yrs

Average board tenure


CEO

Chris Dobbin (45 yo)

no data

Tenure

US$247,214

Compensation

Mr. Christopher Donald Dobbin, also known as Chris, CPA, CA, serves as the Chief Executive Officer and President of Nova Leap Health Corp. and served as its Chief Financial Officer until October 2016. Mr. ...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD247.21K) is above average for companies of similar size in the Canadian market ($USD156.68K).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: NLH's board of directors are considered experienced (3.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: NLH insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.4%.


Top Shareholders

Company Information

Nova Leap Health Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nova Leap Health Corp.
  • Ticker: NLH
  • Exchange: TSXV
  • Founded: 2015
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$53.316m
  • Shares outstanding: 70.15m
  • Website: https://novaleaphealth.com

Location

  • Nova Leap Health Corp.
  • 7071 Bayers Road
  • Suite 5003
  • Halifax
  • Nova Scotia
  • B3L 2C2
  • Canada

Listings


Biography

Nova Leap Health Corp. provides home and home health care services. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, daily living, light housekeep...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/06 23:40
End of Day Share Price2021/05/06 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.